Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

36
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
36
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

42
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
42
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

73
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
73
Regression Toward the Mean01:52

Regression Toward the Mean

6.5K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.5K
Drug Therapy01:28

Drug Therapy

107
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
107
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

54
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
54

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Burden of Respiratory Syncytial Virus Infection in Immunocompromised Adults: A Systematic Review of the Evidence From High-Income Countries.

Infectious diseases and therapy·2026
Same author

Fine Particulate Matter Constituents, Ozone, and Systemic Lupus Erythematosus: A Large General-Population Cohort Analysis With Extended Quantile g-Computation.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Use of Semaglutide and Tirzepatide in Rheumatic and Musculoskeletal Diseases: Insights on Initiation Patterns and Weight Loss From the Rheumatology Informatics System for Effectiveness Registry.

ACR open rheumatology·2026
Same author

Immunosuppressive Medications and Nonserious Infections in People With Rheumatoid Arthritis: A Prospective Cohort Study.

ACR open rheumatology·2026
Same author

Effectiveness and persistence of biological and targeted synthetic treatment in patients with rheumatoid arthritis and chronic kidney disease: a multicentre, prospective cohort study.

The Lancet. Rheumatology·2026
Same author

Evaluating a Smartphone App-Based Module for Joint Self-Assessment as a Complementary Tool in Rheumatoid Arthritis Remote Disease Management.

ACR open rheumatology·2026
Same journal

Reproducible Molecular Subtypes in Systemic Lupus Erythematosus Are Associated With Disease Activity, Serology, and Distinct Trajectories Over Time.

ACR open rheumatology·2026
Same journal

DNASE1L3 Deficiency With Novel Missense Variant: Enzymatic and Plasma Fragmentomic Evidence of Pathogenicity and Partial Response to JAK Blockade.

ACR open rheumatology·2026
Same journal

An Engineered Glove for the Objective Assessment of Hand Dexterity in Patients With Systemic Sclerosis.

ACR open rheumatology·2026
Same journal

International Myositis Assessment and Clinical Studies Guidelines for Risk-Based Cancer Screening: An External Validation in Patients With Dermatomyositis Seen at a Metropolitan Academic Center.

ACR open rheumatology·2026
Same journal

Clinical Images: Skin manifestations and radiographic findings of anti-SAE1 positive dermatomyositis.

ACR open rheumatology·2026
Same journal

Exploring the Shared Genetic Basis of Age at Menopause and Osteoarthritis.

ACR open rheumatology·2026
See all related articles

Related Experiment Video

Updated: Sep 20, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

351

Rheumatologist and Patient Mental Models for Treatment of Rheumatoid Arthritis Help Explain Low Treat-to-Target

Betty Hsiao1, Julie Downs2, Mandy Lanyon2

  • 1Yale University, New Haven, Connecticut.

ACR Open Rheumatology
|June 6, 2022
PubMed
Summary
This summary is machine-generated.

Rheumatologists and rheumatoid arthritis (RA) patients have different views on treatment, impacting the treat-to-target (TTT) strategy. Addressing these information gaps can improve communication and TTT adoption.

More Related Videos

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

385
Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
07:44

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass

Published on: July 14, 2023

1.3K

Related Experiment Videos

Last Updated: Sep 20, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

351
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

385
Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
07:44

Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass

Published on: July 14, 2023

1.3K

Area of Science:

  • Rheumatology
  • Health Communication
  • Patient-Centered Care

Background:

  • Treat-to-target (TTT) strategy offers proven benefits for rheumatoid arthritis (RA) management.
  • Less than half of RA patients are currently treated using the TTT approach, indicating a gap in implementation.

Purpose of the Study:

  • To identify critical discrepancies between rheumatologist and patient mental models in RA treatment.
  • To inform interventions aimed at increasing the implementation of the TTT strategy.

Main Methods:

  • Developed rheumatologist and patient mental models using the Mental Models Approach to Risk Communication.
  • Conducted semistructured interviews with 14 rheumatologists and 30 RA patients.
  • Analyzed survey responses (n=284) to supplement interview data, with independent coding of transcripts.

Main Results:

  • Both rheumatologist and patient mental models are more complex than the standard TTT model.
  • Decision-making incorporates factors beyond disease activity, such as system factors and patient readiness.
  • Unique factors emerged: physicians emphasize disease activity over time and adherence; patients highlight disease weariness, medication fatigue, feeling informed, and medication change stress.

Conclusions:

  • Significant discrepancies exist between patient and physician mental models, particularly concerning information gaps and differing valuation of trade-offs.
  • These identified discrepancies offer specific targets for improving patient-physician communication.
  • Addressing these communication gaps is crucial for enhancing the uptake of the treat-to-target strategy in RA management.